✦ LIBER ✦

P.3.004 Use of the dopamine agonist cabergoline in the management of antipsychotic-induced hyperprolactinemia in schizophrenic patients

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of the dopamine agonists bromocripti

✍ Tollin, Steven R. 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 79 KB

Modulation of angiogenesis by the dopami

✍ E. Novella-Maestre; C. Simon; A. Pellicer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Effects of hyperprolactinemia treatment

✍ Raul Gómez; Antonio Abad; Francisco Delgado; Silvia Tamarit; Carlos Simón; Anton 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 994 KB

P.3.c.073 Cabergoline in the management

✍ J. Cobo; R. Coronas; O. Jiménez-Palop; M. Pérez; R. Mas; L. Ros; G. García-Parés 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

The neuroendocrinological profile of rox

✍ G. Gründer; H. Wetzel; A. Hillert; E. Jochum; C. Hiemke; O. Benkert 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 797 KB

P.3.c.012 The influence of antipsychotic

✍ V. Slavkovic; S. Tosic Golubovic; O. Zikic; D. Gugleta 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 67 KB